PUBLIC COMPANY
save$TARSTarsus Pharmaceuticals, Inc.
$TARS73.01-6.00%Irvine, CA, USupdated 30m ago
community read0 votes
pipeline
3
marketed
1
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
2Phase 21Marketed
Upcoming
no upcoming catalysts on record
Recent(90d)
earnings (1)
Active trials
- phase2A Study to Evaluate the Efficacy and Safety of TP-06 for PCED
- phase2A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure
- phase2Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)
- phase2Pilot Study Comparing the Safety and Efficacy of Two Dosing Regimens of TP-03 for the Treatment of MGD
- phase4Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers
- phase2A Human Tick Kill Study to Investigate the Safety, Tolerability, and Whole Blood Concentration of TP-05
- phase1A Six Week Pharmacokinetic Study of TP-03 in Healthy Subjects
- phase2Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex
🐶 Hiring Signal
News
- BioSpace 2027 Best Places to Work shines light on most admired employersThe list honors 50 life sciences employers of choice. Employees at SERB Pharmaceuticals and CSL Behring share why their companies stand out.biospace · 10d ago
- M&A slows in Q3 but Vertex snags one of the year’s biggest in $10B Crinetics buyAfter a frantic second quarter, M&A steadied with just under $30 billion across 22 total transactions, according to a BioSpace analysis.biospace · 1mo ago
- Alkeus, an unorthodox eye drug startup, acquired by Tarsus for up to $800MAlkeus brought to late-stage testing a Stargardt disease therapy that former executive chairman and Vertex founder Josh Boger once called, “if it works, the most perfect drug I’ve ever seen.”biopharma_dive · 3mo ago
- ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadershipThe ARPA-H program could provide researchers with a roadmap to develop personalized gene editing drugs. Elsewhere, a Botox rival succeeded against migraines and two deals were struck.biopharma_dive · 4mo ago
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that